2019 – Page 19 – MJZanon IP Attorney – Expert Patent & Trademark Lawyer in Brazil

Court upholds the validity and determined Actavis infringement of patent protecting RELISTOR tablets

Wednesday, July 17, 2019 | DrugName: methylnaltrexone bromide Bausch Health Companies Inc. and Progenics Pharmaceuticals, announced that the U.S.

GB Sciences files novel patent application for chronic pain treatments based on proprietary cannabis-derived formulations

Thursday, July 18, 2019 GB Sciences, Inc., through its subsidiary, GBS Global Biopharma, Inc., has filed a novel patent application

Compugen expands intellectual property portfolio for COM701 with new U.S. patent covering combination use with anti-PD-1 antibody

Tuesday, July 16, 2019 | DrugName : COM-701 Compugen Ltd., a clinical-stage cancer immunotherapy company and leader in predictive target

United States Patent and Trademark Office (USPTO) issues U.S. patent covering an enhanced formulation of Pliaglis

Tuesday, July 16, 2019 | DrugName : Pliaglis Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of non-prescription

Spero Therapeutics announces $5.9 million award from U.S. Department of Defense to further clinical development of SPR206

Tuesday, July 16, 2019 | DrugName : SPR-206 Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing